The various multifocal choroidopathies differ in course, prognosis, and treatment. While the prognoses do differ, they are hopeful with early treatment in most cases.
The International Widefield Imaging Study Group (IWISG)—a physician panel with expertise in retinal imaging—has released recommendations for classifications an
Deep learning, a type of artificial intelligence, uses algorithms to recognize patterns.
Anti-vascular endothelial growth factor (VEGF) agents—including aflibercept, bevacizumab, and ranibizumab—have ushered in a new era in the treatment of retinal and choroidal neovascularization.
New research has shown that a longer axial length (AL) may prove protective of incident diabetic retinopathy (DR).1
ICYMI: Dr. Singh shares the take-home message from his 2019 presentation